MESA LABORATORIES INC (24)

Browse by Contract Category

Contracts

Form of 2023 Performance Share Unit Agreement, issued under the 2021 Equity Plan (Filed With SEC on August 4, 2022)
Form of 2021 Restricted Stock Unit Agreement, issued under the 2014 Equity Plan (Filed With SEC on May 31, 2022)
Description of securities registered under section 12 (Filed With SEC on May 31, 2022)
Agreement and Plan of Merger by and Among Mesa Laboratories, Inc., Sky Bearer Corp., Agena Bioscience, Inc., and Telegraph Hill Partners Management Company, LLC as the... (Filed With SEC on September 14, 2021)
Mesa Laboratories, Inc 2021 Equity Incentive Plan (Filed With SEC on May 31, 2022)
Open Market Sale AgreementSMdated April 5, 2022 by and among Mesa Laboratories, Inc. and Jefferies LLC (Filed With SEC on April 5, 2022)
Mesa Laboratories, Inc. 2021 Equity Incentive Plan CEO Special Performance StockUnit Award Agreement with Gary Owens dated October 28, 2021 (Filed With SEC on October 29, 2021)
Executive Employment Agreement dated as of September 29, 2021, by and among Mesa Laboratories, Inc. and Brian Archbold (Filed With SEC on September 29, 2021)
Executive Employment Agreement dated as of September 29, 2021, by and among Mesa Laboratories, Inc. and Greg DiNoia (Filed With SEC on September 29, 2021)
First Amended and Restated Executive Employment Agreement dated as of September 29, 2021, by and among Mesa Laboratories, Inc. and John Sakys (Filed With SEC on September 29, 2021)
First Amended and Restated Executive Employment Agreement dated as of September 29, 2021, by and among Mesa Laboratories, Inc. and Gary Owens (Filed With SEC on September 29, 2021)
Form of 2021 Restricted Stock Unit Agreement, issued under the 2014 Equity Plan (Filed With SEC on June 1, 2021)
Description of securities registered under section 12 (Filed With SEC on June 1, 2021)
Credit Agreement dated as of March 5, 2021 among Mesa Laboratories, Inc., the lenders party thereto, and JPMorgan Chase Bank, N.A., as administrative agent (Filed With SEC on March 8, 2021)
Underwriting Agreement, dated June 9, 2020, by and among Mesa Laboratories, Inc., Jefferies LLC and J.P. Morgan Securities LLC (Filed With SEC on June 12, 2020)
Description of securities registered under section 12 (Filed With SEC on June 1, 2020)
Sale and Purchase Agreement, by and between Goldcup 19534 AB (u.n.c. to Mesa Sweden Holdco AB), Mesa Laboratories, Inc., SLS Invest AB, Ampersand 2014 Limited Partnership, and the... (Filed With SEC on November 4, 2019)
First Supplemental Indenture, dated August 12, 2019, by and between the Company and Wells Fargo Bank, National Association, as Trustee (Filed With SEC on August 12, 2019)
Underwriting Agreement, by and between Mesa Laboratories, Inc., Jefferies LLC and J.P. Morgan Securities LLC, dated August 7, 2019, related to the Notes (Filed With SEC on August 12, 2019)
Amendment No. 3, dated August 7, 2019, to that certain Credit Agreement, dated as of March 1, 2017 between Mesa Laboratories, Inc., JPMorgan Chase Bank, N.A., as administrative... (Filed With SEC on August 12, 2019)
Base Indenture, dated August 12, 2019, by and between the Company and Wells Fargo Bank, National Association, as Trustee (Filed With SEC on August 12, 2019)
Underwriting Agreement, by and between Mesa Laboratories, Inc., Jefferies LLC and J.P. Morgan Securities LLC, dated August 7, 2019, related to the Common Stock (Filed With SEC on August 12, 2019)
Form of 2014 Equity Plan Option Award Agreement as amended (Filed With SEC on July 30, 2019)
Form of 2020 Performance Share Unit Agreement, issued under the 2014 Equity Plan (Filed With SEC on July 30, 2019)